Discussion  by unknown
APPENDIX 1. RACHS-1 DEFINITIONS AND
ALGORITHM USED TO IDENTIFY NORWOOD
Operation
Require:
Dx 746.7 Hypoplastic left heart syndrome
Proc 35.41 Enlargement of existing atrial septal defect
or 35.42 Creation of septal defect in heart
Proc 39.0 Systemic–pulmonary artery shunt
or 35.92 Creation of conduit between right ventricle and
pulmonary artery
Proc 38.35 or 38.45 Resection of thoracic vessel
or 38.34 or 38.44 Resection of abdominal aorta
or 38.64 or 38.65 Other excision of vessel/aorta
or 38.84 or 38.85 Other surgical occlusion of vessel/
aorta
or 39.56, 39.57, 39.58 Repair of blood vessel
or 39.59 or 36.99 Other operation on vessel of heart
Cannot have:
Proc 35.94 Creation of conduit between atrium and
pulmonary artery
Proc 35.95 Revision corrective procedure on heart
Proc 39.21 Cavo–pulmonary artery anastomosis
Allow:
Dx 745.5 Ostium secundum atrial septal defect
Dx 746.3 Congenital stenosis of aortic valve
Dx 746.5 Congenital mitral stenosis
Dx 747.0 Patent ductus arteriosus
Dx 747.10 Coarctation of aorta
Dx 747.22 Atresia and stenosis of aorta
Dx 747.89 Other anomalies of great veins
Proc 37.33 Excision of other lesion/tissue of heart
Cannot have:
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Dr David Clarke (Denver, Colo). The data examined from the
NIS include presumably administrative data from about 20% of
hospitals stratified by location, size, teaching, and so forth. Even
if we assume the sample is representative of the entire country,
intrinsic errors known to exist in administrative data, especially
in the specialty of surgery for congenital heart disease, multiplied
by five does not instill confidence in findings even of this well-
done analysis.
Can you confirm that the source of the information is indeed ad-
ministrative hospital data and ideally say something to boost my
trust in its veracity?
Dr Karamlou. Yes, this is administrative data and although
miscoding is a potential important confounder, this confounder is
not solely isolated to just administrative data. As you know, other
clinical databases are somewhat confounded by differing percent-
ages of miscoding.We have tried to reduce the influence of miscod-
ing by using both a diagnosis for HLHS as well as an accepted
algorithm for coding the Norwood operation, which does not
have a distinct procedure code in administrative data.126 The Journal of Thoracic and Cardiovascular SurgSecond, I think if you look outside of the cardiac surgery and
thoracic surgery literature. the NIS is actually very widely used
in other surgical specialties.
Third, this is an administrative database and thus is based on
billing and things like the final disposition of these neonates and
patients. These are among the factors that are likely to be coded
with greater accuracy than a diagnosis, for instance. However,
your point is well taken.
Dr Clarke. Second, although it is not really clear in your man-
uscript, I learned by talking with you yesterday that your cases were
selected on the basis of criteria including an age of less than or
equal to 30 days at the time of admission. Is it possible that patients
could be admitted more than once and therefore be double counted
in your sampling?
Dr Karamlou. Double counting—you have obviously read the
paper—is another of the potential limitations of this study. One of
the things that it is possible to do in the NIS, and which we hope to
do, is to code patients. You can figure out which infants were trans-
ferred in as their initial diagnosis and so potentially there are two
ways to at least reduce this possible confounding. One is to look
at transfers and admitting diagnosis. The second is to calculate
on a mean prevalence of the incidence of surgical intervention
and apply that constant to the neonates, the 20% that were trans-
ferred; then those patients would fall into the bucket of surgical
intervention, and it may reduce some of that confounding. As
yet, we have not done either of those two things.
Dr Clarke. Third, the overall mortality in this study is reported
as 30%. Although some of the survivors had surgical therapy,
a large group was either transferred to another facility or
discharged alive. We therefore do not really know what happened
to many of these babies. It is likely that most of the transfers
received some form of therapy, and it is very plausible to me
over the years that an increasing number of those who were dis-
charged probably were eventually treated. Do you believe this
study actually represents the evolution of the global management
of HLHS or are we really here just peeking at this horse race
through a keyhole?
DrKaramlou. I think it certainly does represent the evolution of
treatment strategies. What we are stating is that this is the treatment
that is initially provided when a neonate is admitted to a particular
institution. I think the findings of this paper are very important if
you look at certain morphologic subsets of infants with HLHS,
those patients who have an intact atrial septum, for example.
Even if they receive subsequent surgical therapy, it may come at
a great cost to those neonates who probably need to be triaged to
an institution that can provide surgical therapy right then.
The other important thing that you mentioned is that we do not
know the final disposition of the neonates who were transferred.
However, using one of the two methods that I just spoke to you
about, I think it is possible to at least learn a bit more about the per-
centage that were transferred.
Dr David Ross (Edmonton, Alberta, Canada). I am astounded
that you showed such a high rate of nonintervention. In Edmonton,
since 2004, our first-stage mortality is 6% for HLHS, and I know
there are many other centers achieving these results. Yet, when
you talk to neonatologists, it is the only condition for which non-
treatment is offered. There are neonatal and infant cancers that
have far worse survival with far more toxic treatment. If you offerery c January 2010
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Dnontreatment for them, you are told, no, that would be immoral. But
nontreatment is offered to half of the neonates with HLHS. Even
Streptococcal infection in the neonate has a far worse survival,
far worse neurologic survival, and yet no one would ever dream
of not treating it. That is my comment.
My question is this: Do you have any idea why this is continuing
and why these children are singled out for discrimination? Second,
do you have any ideas how to fix this?
Dr Karamlou. I guess I take a little bit of issue with what you
said. I am not making a value judgment that every infant with
HLHS should have surgical therapy. This is actually a dichotomy
that was articulated very well by Martin Elliott in an editorial that
he wrote. That is, in the United States we seem to really favor sur-
gical intervention and it is sort of ‘‘life at any cost,’’ regardless of
the quality of life of those children. This is in contradiction to in the
United Kingdom, for example, or Europe, where nonoperative ther-
apy is selected by a higher proportion of well-educated persons and
even physicians with infants with HLHS. Having said that, I think
one of the primary determinants of nonoperative therapy is that the
infant goes to an institution that does not provide surgical manage-
ment. I think that is one of the important findings in this study.
Dr Thomas Spray (Philadelphia, Pa). Despite the fact that we
may not want to believe your results, I think they are probably
valid. If you go to a national meeting with a group of pediatric car-
diologists and you ask themwhether they offer nonintervention, the
majority say yes. In fact, if you ask them what they would do with
their own child, the majority would say nonintervention. So your
study may actually reflect the true situation.
I would like to make a comment again about these administrative
data sets. If you believe that only 20% of the data is represented,
you would believe that there were 45,000 or more children with
HLHS born in the time frame of the study, which is probably
a vast overestimate of the number in the United States, at least.
That probably is not correct. If you look at an individual institution
and you look at the coding, when we tried to do that in our institu-
tion there was at least a 30% discrepancy in terms of coding accu-
racy, and this is not validated data. That is one of the real problems
with your study, and we are seeing more and more studies using
these national data sets. I would only suggest that maybe something
worth considering is a control population. Take a group in which
you would assume that there is pretty consistent intervention, say
transposition, and in the same data set look at what happens
when you look at transposition rather than HLHS. Do they get
transferred? Do they get operated on? Are they offered noninter-
vention? If you see that there is a relatively high incidence of non-
intervention, then it would lead me to believe that these data sets areThe Journal of Thoracic and Canot really accurate. Then there is the whole problem, as was already
brought up by Dr Clarke, that you do not track what happens to the
individual patient; if the patient is transferred, that patient may get
nonintervention or the patient may get intervention. For the patients
who are classified as nonintervention in your group, you do not
know whether every one of those patients died while they were
in the hospital (which theoretically they should have if they were
given comfort care and nonintervention). It is important to track
what happens to these patients or really you are just getting a snap-
shot. Now this is the best data set there is, and I concede that, but I
just would suggest that you might want to try to use control popu-
lations to see whether you can sort out whether this is really accu-
rate.
Dr Karamlou. I think that is an excellent idea, Dr Spray. I think
I would just mention that even though we do not know the final dis-
position of the transferred neonates, that is still only 20% of our
sample. Good idea.
Dr Lawrence Cohn (Boston, Mass). I have one question. This is
outstanding that in the United States of America 57% of patients
with a potentially treatable disease are not treated. I want to ask
a question concerning the coding. Is this premortem or postmor-
tem? Is this, in part, due to a big diagnostic problem? In other
words, are all of these patients diagnosed with this syndrome as
they come in and then given comfort care, or is this a postmortem
diagnosis, with the patients being signed out on the administrative
log and we say that they were given comfort care because the diag-
nosis was unknown?
Dr Karamlou. If that is true, then a large proportion of infants
had the Norwood operation or transplant not for HLHS, which I
find difficult to believe. Most of these diagnoses are administra-
tively coded. I would assume that the majority of them are done
preoperatively or before intervention, but there is no way to be
sure whether or not necropsy findings were used in a proportion
of them.
Dr Cohn. I just meant in the comfort care group where nothing
was done, were these premortem or postmortem diagnoses?
Dr Karamlou.No, because a lot of the infants who had comfort
care actually did not die in the hospital. In a large percentage of
cases, the parents chose to take the neonates home so that they
could die at home, so it would be a premortem diagnosis.
Dr William Brenner (Los Angeles, Calif). In 1977, the late
great Helen Taussig shocked an audience at the Los Angeles Heart
Association when somebody asked her about the future of congen-
ital heart disease. She responded amniocentesis and abortion. That
is not what the audience was expecting.
Dr Karamlou. I am not advocating that either, by the way.rdiovascular Surgery c Volume 139, Number 1 127
